Shariah compliance overview
Not HalalImmunovant, Inc. (IMVT) is currently classified as Not Halal by Akinda Shariah screening (AAOIFI-aligned methodology).
About Immunovant, Inc.
Immunovant, Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to advancing novel monoclonal antibody therapies for the treatment of various autoimmune conditions. The company's primary focus is batoclimab, a pioneering, fully human monoclonal antibody.
Immunovant, Inc. (IMVT) operates in the Healthcare sector, in the Biotechnology industry.
Why it is not classified as halal: it does not pass these screens: Business Activity.
- Business Activity
- 100.00%Limit 5%Fail
- Interest-bearing debt
- 12.25%Limit 30%Pass
- Interest-bearing securities and assets
- 20.32%Limit 30%Pass
- Dividend purification
- 100.00%Share of dividends to give to charityPurification calculator
Last updated: Nov 3, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.
Please login to access this content
Please login to access this content
Please login to access this content
Company Profile
Please login to access this content
Frequently asked questions
Quick answers about Immunovant, Inc. (IMVT). Current Akinda screening label: Not Halal.
